Cargando…
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has been associated with low blood levels of monocyte chemotactic protein-3 (MCP-3), macrophage inflammatory protein-1 alpha (MIP-1α), vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (...
Autores principales: | Späth, Florentin, Wibom, Carl, Krop, Esmeralda J. M., Santamaria, Antonio Izarra, Johansson, Ann-Sofie, Bergdahl, Ingvar A., Hultdin, Johan, Vermeulen, Roel, Melin, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959165/ https://www.ncbi.nlm.nih.gov/pubmed/30948485 http://dx.doi.org/10.3324/haematol.2019.216895 |
Ejemplares similares
-
Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients
por: Tahiru, Widad, et al.
Publicado: (2022) -
Pre‐diagnostic levels of sVEGFR2, sTNFR2, sIL‐2Rα and sIL‐6R are associated with glioma risk: A nested case–control study of repeated samples
por: Wu, Wendy Yi‐Ying, et al.
Publicado: (2022) -
Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study
por: Späth, Florentin, et al.
Publicado: (2016) -
Troponin T but not C reactive protein is associated with future surgery for aortic stenosis: a population-based nested case-referent study
por: Holmgren, Anders, et al.
Publicado: (2020) -
Blood Erythrocyte Concentrations of Cadmium and Lead and the Risk of B-Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma: A Nested Case-Control Study
por: Kelly, Rachel S., et al.
Publicado: (2013)